Working Life: Biologics have been a game-changer for some patients with asthma
'I was fairly agnostic early on in my medical training and wasn't sure what I wanted to specialise in, but I was always interested in infectious diseases and autoimmune diseases and physiology, which the area of lung diseases lends itself to.
'What really interested me about respiratory medicine is that it deals with both the acute and chronic side.
'You have patients with acute respiratory failure, which is the emergency side, as well as patients with long-lasting conditions who need help managing their disease.
'I specialise in the severe asthma sphere. The arrival of biologics has been a game-changer for some of my patients with severe asthma. People have gone from not being able to work or exercise, or participate in life, to being able to do all those things.
'One of the most satisfying parts of my job is when a patient who has started a new treatment tells me, 'This has massively improved my quality of life'.
'Covid had a huge impact, especially working as a lung doctor in Canada where we were when it kicked off. My mum passed away when we were abroad, and watching her funeral over Zoom was really tough as we weren't able to travel home to Ireland. I understand the rationale behind the travel restrictions, but it was still really tough.
'One of my chief bugbears as a doctor is the lack of an integrated national electronic patient healthcare record system. I consider it a public health emergency.
'It would enhance patient care greatly if every practitioner could access patients' medical records. Our wait lists would drop, efficiency in the system would improve exponentially, and the cost of care would decrease.
'As an academic consultant, I work 50% of the time for Trinity College Dublin. I'm a medical advisor to the Asthma Society of Ireland, and supporter of its Active for Asthma campaign, which encourages people with asthma to safely incorporate physical activity into their lives — it's a superb initiative.
'I love a lot of what I do, but it can be hard to switch off from the job. I enjoy downtime with family — my wife Claire, a GP, and our three kids, Anna, 11, Laura, 9, and Ben, 7.
'I also love being back in Ireland — it's home.'
It's Asthma Awareness Week. See: asthma.ie
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Post
4 hours ago
- Irish Post
How Riley is changing period care in Ireland and beyond
WHEN Fiona Parfrey speaks about period care, she doesn't mince words. 'We want period products to be treated just like toilet paper; something that's readily available in every bathroom you walk into,' she says. Parfrey is the co-founder of Riley, a rapidly growing Irish startup that's shaking up the period care industry—not just with sustainable products, but with a bold mission to break the silence and shame around menstruation. 'We're aiming to remind people it's a normal bodily function,' she says. 'There's nothing to be ashamed about.' Born and raised in Cork, Parfrey studied marketing at University College Cork. 'I'm a very proud Corkonian,' she laughs. 'I studied marketing and worked in agencies across Dublin and Australia, and then I moved into the startup world in Australia. That's where I kind of fell in love with entrepreneurship.' That love turned into a career. After leaving her job in Australia, Parfrey went backpacking around the world, which sparked her first business idea. 'I realised there was a gap in the market for a travelling backpack that was ergonomically designed to fit the female body,' she says. 'A lot of the backpacks on the market were bulky and hard to carry for women. So I created a backpack that was made using recycled plastic.' The brand, Sundrift, gained traction until the COVID pandemic disrupted the travel industry and forced Parfrey to shift gears. That pivot led to Riley. The idea for Riley wasn't born in a boardroom or a brainstorm session. It happened over wine with a friend. 'The conversation happened quite naturally one evening,' Parfrey says. 'We were talking about how frustrated we were with the period products we had been using our entire lives.' That frustration turned into a revelation. 'We discovered that many mainstream period products are manufactured with up to 24 hormone-disrupting chemicals and covered in plastic,' she says. 'There were so many unnecessary ingredients in the manufacturing process. We felt like surely there's a better way of doing this.' When they couldn't find a cleaner, more sustainable alternative on the Irish market, Parfrey and her co-founders decided to build one themselves. Riley launched in 2021 as an e-commerce subscription service delivering organic, plastic-free period products directly to consumers' doors. 'We knew that when we started to build something clean, it would not only be better for our bodies but better for the planet as well,' Parfrey says. Sustainability isn't a marketing buzzword for Riley; it's a core principle of the business. 'Our applicators on our tampons are made from a bio-based solution, derived from sugarcane,' Parfrey notes. 'And we try to keep the environment in mind in every element of our supply chain.' But it hasn't been easy. 'It's a real journey to make things as sustainable as possible as we grow the business." Riley has since expanded from its consumer-focused model into the corporate space. 'We've started a big corporate offering,' Parfrey says. 'We supply period products to companies so they can stock them in staff bathrooms, just like they stock toilet paper. It's about making period care accessible, visible, and normal.' Parfrey is encouraged by how Ireland has responded to the brand and its mission. 'It's been really refreshing how open people have been, across generations, across genders, to actually talking about this,' she says. 'We've been really pleasantly surprised by the support we've gotten from all types of people.' But she's quick to note that stigma still lingers. 'If you survey young girls in school, 50% of them still feel shame when they're talking about periods. That's a huge problem,' she says. 'We've made progress, but we still have a long way to go.' The issue, she believes, goes far beyond just product accessibility. It's cultural, educational, and deeply gendered. 'Women go through a lot in their lifetime; from periods to childbirth to menopause and everything in between,' Parfrey says. 'It's important not just that women understand what's going on in their bodies, but that men do too.' She's especially passionate about closing the knowledge and research gap in women's health. 'There's been more research and studies on male baldness than there has been on endometriosis. That's shocking.' Riley was launched in 2021 (Photo by Riley) Riley is a proudly Irish company, but built to scale. 'We're an Irish-registered company,' says Parfrey. 'I'm based in Cork; we have a small office here and another in Dublin. My co-founder, Áine, has moved over to London as we try to grow the business in the UK.' That international push is already bearing fruit. 'Our supply chain is set up to serve all of Europe, and we have clients and direct customers all throughout Europe,' Parfrey says. 'We absolutely have global ambitions. The beauty of this business is that periods transcend borders, cultures, and languages. It's such a common thing for women no matter where they come from.' Reflecting on her startup journey, Parfrey encourages others not to wait for perfection. 'Just launch a minimum viable product. Get something to market and learn from your early adopters. If we had waited to launch a perfect product, we still wouldn't be in the market today.' Listening to feedback, she says, has been critical. 'Be close to your customer. Take their feedback on board. We constantly try to improve and make changes as we grow.' 'The more we talk openly about periods, the more we understand each other,' she says. 'And the easier it will be for everyone.' Whether it's tackling sustainability or breaking stigma in boardrooms and classrooms, Riley is charting a new course, one that's not just better for the body, but better for the planet too. See More: Business, Period Care, Startups
The Irish Sun
9 hours ago
- The Irish Sun
‘Suspicious' antivax mum accuses paramedics of ‘killing' model daughter after she refused ‘lifesaving' cancer treatment
CONSPIRACY theorist Kay "Kate" Shemirani has accused paramedics of killing her daughter after she refused lifesaving cancer treatment, an inquest has heard. Paloma Shemirani, a 23-year-old University of Cambridge graduate, collapsed on July 19 last year and was taken to Royal Sussex County Hospital. 9 Paloma Shemirani died from a heart attack after being diagnosed with cancer Credit: Facebook 9 Paloma's mum, Kate, is a notorious anti-vaxxer and conspiracy theorist Credit: Alamy 9 The 23-year-old turned down treatment for non-Hodgkin lymphoma Credit: Facebook She died just five days later, on July 24 of a heart attack. Just months earlier, Paoloma, who was a finalist in Miss Universe Great Britain 2021 , had declined treatment for - a type of blood cancer which starts in the lymph nodes. Her mother, Kate who rose to prominence on social media while sharing Kate, who was involved in Paloma's "alternative treatment" called her friend before calling an ambulance the day her daughter collapsed, the inquest at Kent and Medway Coroner's Court in Maidstone, heard. Read more on Paloma On Wednesday, reading a prepared witness statement, she accused the inquest of "attempting to shift focus" from the "real" cause of Paloma's death. "Any attempt to place responsibility on me is false - the people who need to be answering are those who failed to confirm diagnosis, administered drugs without her consent which could have damaged her heart," said Kate. Kate told the court that a "sequence of medical actions" caused her daughter's death, which she claimed amounted to "gross negligence manslaughter". She claims that while in hospital in December 2023, Paloma was given medication without her consent and felt "pressured and bullied" by medical staff. Most read in Health "I became very suspicious and deeply concerned about what was happening," Kate told the coroner. Paloma's twin brother, Gabriel Shemirani, suggests that when Paloma was first diagnosed, she was considering chemotherapy, before their parents started to pressure her against it. Son of anti-vax nurse being probed by cops for comparing NHS medics to Nazis slams 'arrogant' mum Kate was struck off as a nurse in 2021, having qualified in the 1980s and a Nursing and Midwifery Council (NMC) committee found she had spread Covid-19 misinformation that "put the public at a significant risk of harm". After her stay in hospital in December 2023, Paloma began an alternative treatment programme which included daily coffee enemas, a strict diet and green juices, the inquest heard previously. "Paloma made her own treatment choices based on her values, research and experiences," said Kate. She added that her daughter was "never a victim of coercion" and that she "continued to improve physically" under her alternative medicines. "She was determined to get well on her own terms and this is well documented in her own high court statement which was read out in this coroner's hearing" said Kate. On the day she collapsed, she had an appointment with an osteopath, Nick Gosset, who described her on Wednesday as "a young lady who was in the last stages of a very difficult disease" and said he advised she seek medical help. 9 Paloma's twin brother, Gabriel Shemirani, previously blamed Kate for her death Credit: PA 9 Paloma was considered chemo before her parents got involved, Gabriel claims Credit: Facebook 'She's dying' Today, her mother disagreed saying: "On the morning of July 19 Paloma was well. "She looks healthy and good colour ... she was smiling and laughing, she was not as described yesterday by the osteopath." Paloma collapsed at home later that day, and her mother called her friend who then called an ambulance while they initiated CPR. On the 999 call played to the court, Kate was heard shouting "she's dying" to the operator before the paramedics arrived. She also told the ambulance operator "it's difficult to lie her on her front because she has a medicinal mass" in her throat, the inquest heard. In her evidence, Kate told the court that when the paramedics arrived they administered adrenaline "then everything went horribly wrong" following their intervention and her daughter went into "full circulatory collapse". "I knew at this point that they'd done something, given something that had caused this," she said. 9 Paloma began an alternative treatment programme which included daily coffee enemas, a strict diet and green juices Credit: Facebook 9 Kate told the court that a 'sequence of medical actions' caused her daughter's death Credit: Facebook 9 Kate has has accused paramedics of killing the Cambridge grad Kate added: "She deteriorated catastrophically upon their arrival and their intervention." Dr Anderson said Paloma received a standard adult dose of adrenaline during the cardiac arrest, and that this was acceptable even given how thin she was at the time. Paloma was taken to Royal Sussex County Hospital in Brighton on a ventilator, and brain stem death was declared on the afternoon of July 24, 2024 after a series of nationally advised medical checks. 'Trying to conceal cause of death' Kate said the decision taken was rushed and said that the brain stem testing was not the same in the UK as it was in the US, and wanted an MRI. Intensivist and anaesthetist Dr Peter Anderson, who was on shift when Paloma died, explained: "I thought the risk of deterioration and uncontrolled death was extremely high." Dr Anderson noted that on the 999 call, Kate called out Paloma's oxygen saturation which was "critically low" at 36 then 35. He told the coroner that if Paloma's 'sats' were that low for a significant time then the brain damage was done before the paramedics arrived. Kate said: "We are deeply concerned this inquest is attempting to shift focus on the cause of death." Later she added: "We believe this to be an attempt to pervert the course of justice and conceal the cause of Paloma's death." The inquest continues. 9 Paloma received a standard adult dose of adrenaline during the cardiac arrest from the paramedics, a doctor said Credit: Facebook Non-Hodgkin lymphoma treatment, as recommended by the NHS Non-Hodgkin lymphoma is usually treated with chemotherapy or radiotherapy, although some people may not need treatment straight away. In a few cases, if the initial cancer is very small and can be removed during a biopsy, no further treatment may be needed. If non-Hodgkin lymphoma is low grade (slow developing) and a person is well, a period of "watch and wait" is often recommended. This is because some people take many years to develop troublesome symptoms and starting treatment immediately is often felt to be unnecessary. But in other cases, chemotherapy is used to kill cancer cells. If non-Hodgkin lymphoma doesn't get better with initial treatment (known as refractory lymphoma), you may have a course of chemotherapy at a stronger dose. But this intensive chemotherapy destroys your bone marrow, and can lead to the following side effects: Nausea and vomiting Diarrhoea Loss of appetite Mouth ulcers Tiredness Skin rashes Hair loss Infertility, which may be temporary or permanent A stem cell or bone marrow transplant is then needed to replace the damaged bone marrow. Radiotherapy is most often used to treat early-stage non-Hodgkin lymphoma, where the cancer is only in one part of the body. And for some types of non-Hodgkin lymphoma, you may have a type of medicine called a monoclonal antibody. These medicines attach themselves to both healthy and cancerous cells, and signal to the immune system to attack and kill the cells. Other potential non-Hodgkin lymphoma treatments include: Cancer growth blockers Steroid medicine Immunotherapy Source: NHS
Irish Times
15 hours ago
- Irish Times
EY Entrepreneur of the Year profiles: From wellness and hair taming to organic bread baking
Laura Dowling, FabÜ Laura Dowling, founder of fabÜ Laura Dowling is the founder of FabÜ, which is an Irish wellness brand specialising in scientifically formulated supplements that blend plants, including herbs, and mushrooms with essential vitamins and minerals. It launched in 2022 and is available in more than 1,500 pharmacies and health-food stores across Ireland, as well as online. A graduate of the Trinity College Dublin School of Pharmacy, Dowling has more than 350,000 followers on social media. What vision/light-bulb moment prompted you to start up in business? I identified a gap in the market for scientifically grounded supplements, rather than those based on hype. That's why I developed FabÜ – natural, effective products that support long-term health. So many women also struggle with incontinence, vaginal, sexual, and hormonal issues. They don't know who to turn to for help. They often feel ignored or fobbed off. That's what led me to create my sell-out Viva La Vulva shows. READ MORE Describe your business model and what makes your business unique. FabÜ combines scientific formulations with relatable education. We create targeted supplements based on research, sell through over 1,500 retailers and online, and connect with consumers through trusted digital content. Our blend of science, pharmacist-led insight, and authentic wellness advocacy sets us apart in a crowded space. What is your greatest business achievement to date? Building FabÜ into one of Ireland's fastest-growing wellness brands in just three years. The incredible feedback and word-of-mouth recommendations from Irish women has led to multi-award recognition and distribution in over 1,500 stores nationwide. Multiple sell-out shows in the National Concert Hall with my Viva La Vulva tour, and recently being named Ireland's Pharmacist of the Year have also been proud milestones. What was your back-to-the-wall moment and how did you overcome it? I initially attempted to launch over a decade ago, but as a young mother with a full-time pharmacy job, I struggled to make it work. I lacked financial know-how and time. In 2022, I tried again – this time building the right team around me. Knowing my blind spots made all the difference. [ EY Entrepreneur of the Year profiles: From aviation finance software to changing private dermatology Opens in new window ] What moment/deal would you cite as the game changer or turning point for the company? Securing national pharmacy distribution early on was pivotal. It validated our product credibility and scaled awareness rapidly. That visibility, combined with a strong digital presence, created a flywheel effect that continues to propel FabÜ. What were the best and the worst pieces of advice you received when starting out? Best advice? 'Launch, then learn.' My first attempt didn't work – but the feedback it gave me was gold. Iteration is how great businesses are built. The worst: 'Don't mix personal brand with business.' In reality, my authenticity has been a key driver of FabÜ's success; people connect with individuals, not just products. To what extent does your business trade internationally and what are your future plans/ambitions? We currently focus on Ireland but are laying groundwork for expansion into the UK and Europe. International demand is growing through our online store, and global retail partnerships are part of our future roadmap. How will your market look in three years and where would you like your business to be? Consumers will demand transparency and science-backed solutions. I envision FabÜ leading this evolution with a deeper reach into Europe, an expanded product range and a stronger voice in shaping meaningful wellness conversations. What are you doing to disrupt, innovate and improve the products or services you offer? Every FabÜ blend is grounded in research and innovation. We continuously review emerging clinical studies and listen to real-world consumer feedback to develop our formulations. I let my personality shine through when I communicate. Being authentic is important. Sometimes, even serious topics like illness, ageing and the changes our bodies go through can be discussed with a pinch of humour – that way, it's more likely to be remembered, shared and acted upon. How are you deploying AI in your business and what impact has it had on your performance? We're integrating AI into customer insights, demand forecasting and content optimisation. It's helped streamline operations, sharpen messaging and improve service delivery. What is the most common mistake you see entrepreneurs make? Chasing trends over purpose. Building a sustainable business requires clarity, consistency and authenticity – especially in wellness. If your mission is muddled, your brand and customer trust will be too. What is the single most important piece of advice you would offer to a less experienced entrepreneur? Know your purpose and live it every day. That clarity fuels resilience, helps you navigate setbacks and builds trust with your team, your customers, and yourself. Your 'why' serves as your strongest anchor. Running a business is all consuming. At times it can feel like you're on a fast-moving train that's impossible to jump off. So be prepared, stay grounded and hold on to your hat. Áine Kennedy, The Smooth Company Áine Kennedy, founder of The Smooth Company Áine Kennedy founded The Smooth Company from her attic in February 2022 after spending eight years working in the beauty industry. Its first product was the Smooth Stick, which is a 'hair-taming' wand that controls stray hairs without leaving hair hard or greasy. The company has amassed more than 150 million organic TikTok views, has customers in more than 70 countries and has featured in Vogue and Elle magazine. Its product range is sold in Brown Thomas, Arnotts, 72 Peter Mark salons, and on board 432 global Aer Lingus routes. What vision/light-bulb moment prompted you to start up in business? I had two business ideas before that I did not pursue, and I regretted it. So when I saw the gap in the market for a product like the Smooth Stick I knew I had to take the plunge. Like many people, I have always suffered with frizzy, stray hairs and I saw a common trend on social media of people dipping their toothbrush into gel to try to keep their hair in place, or else spraying loads of hairspray which leaves your hair hard or greasy. I wanted to create an easy to use solution to this that was kind and nourishing to your hair and was a brush out formula. After two years of formulating, the Smooth Stick was born. Describe your business model and what makes your business unique. The Smooth Company has been self-funded from day one. This was an intentional choice to ensure we kept full control of company direction and growth without having to worry about pleasing shareholders. The company has scaled through organic online growth, using social media and a unique content strategy to drive brand awareness and online sales direct to our own website. What is your greatest business achievement to date? A recent huge achievement has been becoming the first Irish beauty brand to launch into De Bihenkorf stores (a sister company to Brown Thomas Arnotts) across the Netherlands. What was your back-to-the-wall moment and how did you overcome it? We had to deal with our whole website being pirated. Someone took all of our content from our website and made a website impersonating us. They took all our imagery and edited out our branding and began running Meta ads using our content to drive traffic to this fake website to steal people's card details. It was a really stressful time as it wasn't something we had faced before. I posted a video on TikTok warning our followers about the scam website and we received an outpouring of support and people offering to help us. As a result, we managed to get the fake website down within 48 hours. It proved the point to me to never be afraid to ask for help when you need it. What moment/deal would you cite as the game changer or turning point for the company? Brown Thomas being our first ever retailer was a huge game changer for us. It positioned us exactly where we wanted to be in the market and proved to the consumer how high quality our products are. To what extent does your business trade internationally and what are your future plans/ambitions? Over 50 per cent of our online business is international. We have customers in over 70 countries around the world and have had an online order to every state in the USA. Our second biggest export market is currently the UK. We have huge plans for international expansion. Describe your growth funding path. We are focused on scaling through strategic partnerships rather than equity investment. We plan to bootstrap the business for as long as we can. What makes your company a good place to work? Our company excels in offering a flexible and inclusive work environment where employees manage their working hours and locations, fostering a trust-based culture. In contrast to typical corporate structures, we do not enforce a fixed 'back to office' policy, allowing our team the freedom to excel independently. Annual leave is exclusively for holidays, with unlimited personal time off for health, childcare and other commitments. What impact have Donald Trump's tariffs had on your business? How has this affected your view of the United States as a place in which to invest? We anticipated the tariffs and took strategic actions. Amazon USA contributes $20,000 monthly through FBA sales (Fulfilment by Amazon sales, a service where Amazon handles storage, packaging, and shipping for sellers), so we pre-emptively sent a six-month supply of stock. Additionally, a US fulfilment company manages our online orders, avoiding import tariffs for our customers. Eoin Cluskey, Bread 41 Eoin Cluskey, Bread 41 founder and head baker Eoin Cluskey is the founder and head baker at Bread 41, a sourdough bakery and organic food business based in Dublin. A former accountant who became an artisan baker, Cluskey trained in Ballymaloe and honed his craft in bakeries across Europe before launching Bread 41 in 2018. Bread 41 is a bakery and eatery located on Pearse Street in Dublin. It employs more than 100 people across its bakery and shop. It specialises in organic, naturally fermented breads, handcrafted pastry and locally sourced wholefoods. The business is expanding, with plans for a new production facility and a grain mill. What vision/light-bulb moment prompted you to start up in business? While travelling and working in bakeries across the world I saw how bread could be a force for connection and sustainability. The light-bulb moment came when I realised Ireland was missing that: a bakery that is rooted in craft, values and community. Bread 41 was born to bring real bread, and better food systems, back to the table. Describe your business model and what makes your business unique. Bread 41 is built on sustainability, community and craft. We bake everything fresh daily using organic, Irish-milled flours and long fermentation. Unlike conventional bakeries, we avoid additives and embrace slow, regenerative processes. We also educate, collaborate with farmers and aim to shift the food system toward local, healthy and resilient practices. What is your greatest business achievement to date? Building a business that's not only profitable but values led. I'm proud that Bread 41 has become a beacon for sustainable food in Ireland, influencing public perceptions of bread, waste and sourcing. What was your back-to-the-wall moment and how did you overcome it? The pandemic hit us hard, with overnight closures, safety challenges and financial uncertainty. We pivoted fast: started online deliveries, rebuilt supply chains and stayed open for the community. It was about resilience and purpose. What moment/deal would you cite as the game changer or turning point for the company? Opening our doors in 2018 and seeing people queue for real bread was game-changing. But launching our fermentation lab and expanding into wholefood meals signalled a turning point, Bread 41 wasn't just a bakery any more. It became a movement. What were the best and the worst pieces of advice you received when starting out? Best: 'Build a business around your values, not just a product.' Worst: 'Scale quickly, there's no time to waste.' We've taken the opposite approach: slow, deliberate, values-led growth is what's sustained us. Describe your growth funding path. We've grown organically and reinvested profits rather than chasing external capital. That's kept us in control of our mission. Now, we're exploring values-aligned funding for infrastructure projects, like a regenerative grain mill and a new production facility. What are your annual revenues and profits? We are a privately held company, but our growth has been steady and healthy. We focus on long-term sustainability, not short-term profits. That model has allowed us to scale while staying true to our mission. What are you doing to disrupt, innovate and improve the products or services you offer? We're reimagining food systems, from working with regenerative farmers to reviving heritage grains and fermentation methods. We upcycle waste, test zero-waste packaging and innovate with plant-based menus. What makes your company a good place to work? We offer flexible hours, free meals, supported learning and a culture of respect. Our team is united by a common purpose: feeding people with integrity. We invest in growth, mental wellbeing and sustainability. Diversity and inclusion are embedded, and everyone's voice matters in shaping the future of Bread 41. What impact have Donald Trump's tariffs had on your business? How has this affected your view of the United States as a place in which to invest? We source locally, so the impact was minimal. However, it reminded us how vulnerable global supply chains can be. What is the most common mistake you see entrepreneurs make? Prioritising scale over purpose. Growth without a clear mission or culture creates cracks. Many entrepreneurs overlook the human and environmental side of business in the rush for success. That's a short-term win, but a long-term risk. What is the single most important piece of advice you would offer to a less experienced entrepreneur? Get crystal clear on your 'why'. That clarity will guide your decisions, help you weather storms and attract the right people. Build a business that serves not only your customers but also your community, your team and the planet. Liam Dunne, Klearcom Liam Dunne, Klearcom co-founder and chief executive Liam Dunne is the co-founder and chief executive of Klearcom. Headquartered in Waterford, it provides global digital voice and contact centre testing products for multinational companies. Underpinned by its growing base of more than 340 carriers, Klearcom's services and products are used in more than 100 countries. What vision/light-bulb moment prompted you to start up in business? I've always had the desire to build something of my own. While I was involved in a couple of start-ups before, I was more of a minority shareholder than a leader. Klearcom was my opportunity to take the reins. Along the way, I explored various ideas, including a contact centre as a cervice (CCaaS) start-up and two accelerator projects with the National Digital Research Centre, both of which didn't work out. The real light-bulb moment came when Pfizer approached us to test interactive voice responses (IVRs) and voicebots in-country. Competitors claimed they could deliver, but they fell short. That gap was impossible to ignore, and that's how Klearcom was born. Describe your business model and what makes your business unique. We ensure that global brands remain connected to their customers by providing reliable solutions for toll-free numbers, IVRs and voicebots. What sets us apart is our focus on live production assurance, outage triage and multilingual testing at scale. We leverage AI-driven solutions and offer custom builds that address unique challenges, ensuring that we deliver what no one else can. What is your greatest business achievement to date? For me, it's all about not giving up and always stepping up to the challenge. We took a simple idea and turned it into a platform that big names like Pfizer, Google and Mastercard trust to enhance their customer experience. Building that level of trust on a global scale by delivering results under pressure is what I'm most proud of. It's a bigger win than any product launch or marketing campaign we could have imagined. What was your back-to-the-wall moment and how did you overcome it? I hit a real low when early funding dried up, and I had two other ideas that didn't pan out. I ended up selling my rental property, which was my safety net, essentially my pension. Thankfully, my wife believed in me and encouraged me to keep pushing forward. We focused on building a minimum viable product (MVP), showcased it to Pfizer, secured new funding and delivered results. That leap of faith still drives us today. What moment/deal would you cite as the game changer or turning point for the company? Winning Pfizer was a game changer for us. That success opened doors to big names like Google, Mastercard and HP. What were the best and the worst pieces of advice you received when starting out? The best advice I received was to trust my gut; you really do know when something feels off. On the flip side, the worst advice was to play it safe. Playing it safe can kill ambition. It's those bold moves that scare you that often lead to the biggest changes. To what extent does your business trade internationally and what are your future plans/ambitions? We test voice services in over 100 countries daily. As voice shifts from IVRs to digital voice and AI, we will be the standard that global brands rely on. We are building for 10 years ahead, not just the next market. Describe your growth funding path. We raised €2 million through oversubscribed funding rounds with Furthr VC, HBAN, Bloom and Enterprise Ireland. Every euro was aimed at growth, and now we're gearing up for significant expansion as we dive into the digital voice migration. How will your market look in three years and where would you like your business to be? Digital voice technology will become smarter, more complex and increasingly challenging to implement correctly. While the technology is mostly ready for English, other languages are just starting to catch up. We're focused on long-term leadership rather than quick wins, as each new language that supports digital voice will need thorough testing. What are your annual revenues and profits? We are nearing $10 million in annual recurring revenue, and are already highly profitable. How are you deploying AI in your business and what impact has it had on your performance? AI is at the core of everything we do, from our sales processes to our onboarding platform. It helps us identify issues before our customers even notice, making us faster and sharper in our operations. We're truly AI-first, both in our design and our company culture.
